Unique Surface Structures on Synovial Cells
滑膜细胞独特的表面结构
基本信息
- 批准号:6478501
- 负责人:
- 金额:$ 28.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1986
- 资助国家:美国
- 起止时间:1986-08-01 至 2007-03-31
- 项目状态:已结题
- 来源:
- 关键词:CD antigens T lymphocyte apoptosis biomarker cell adhesion molecules cell cell interaction cell morphology clinical research cytokine disease /disorder model fibroblasts gene expression human subject human tissue leukocyte activation /transformation microarray technology monoclonal antibody patient oriented research rheumatoid arthritis synovial membrane
项目摘要
DESCRIPTION (provided by the applicant): In rheumatoid arthritis (RA)
inflammation and ultimate destruction of articular structures are accompanied
by extensive infiltration of synovium by T lymphocytes and macrophages, and
hyperplasia of synovial fibroblasts (SF). The role of T lymphocytes remains
controversial, with no conclusive proof for T cell directed autoimmunity as the
cause of RA. We have taken several approaches to better understand pathways of
T cell activation and of the role of T cells in RA, including generation of
monoclonal antibodies to novel T cell surface antigens, and ligands of surface
structures important for T cell activation, including ligands expressed on SF.
In addition we have developed evidence that T cells, even resting T cells, can
interact with SF in a bi-directional manner. Thus SF can function as potent
accessory cells for T cell activation, while resting T cells can stimulate a
proinflammatory pattern of gene expression in SF, even in the absence of
stimuli that activate the T cell. We have termed this ability of unactivated T
lymphocytes to stimulate the SF "effector function of resting T cells." We now
propose that a significant component of the aggressive behavior of SF in RA
arises from direct interactions between T cells and RA SF. We also hypothesize
that the molecular basis for this unusual and pathogenic program of cell
differentiation arises from a unique immunologic synapse formed between the T
lymphocyte and the SF. The current proposal would further analyze the molecular
interactions between T cells and SF and the functional consequences of these
interactions, using both morphologic and immunologic approaches. A novel ligand
of CD6 expressed by SF will be molecularly characterized and functionally
studied. New antibodies will be generated to analyze the T cell/SF microarray
analysis of SF gene expression, and quantitative interaction, directed at both
known and novel cell surface molecules and at the secreted CD26-related cell
interaction molecule attractin. Activation of SF will be studied using
measurement of relevant RNA species and protein products, such as osteoclast
differentiation factor, cytokines, and tissue destructive proteases. The
proposed studies represent a fresh approach to understanding RA.
描述(由申请人提供):用于类风湿关节炎(RA)
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Alan Fox其他文献
David Alan Fox的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Alan Fox', 18)}}的其他基金
University of Michigan Clinical Autoimmunity Center of Excellence
密歇根大学临床自身免疫卓越中心
- 批准号:
10662184 - 财政年份:2019
- 资助金额:
$ 28.39万 - 项目类别:
University of Michigan Clinical Autoimmunity Center of Excellence
密歇根大学临床自身免疫卓越中心
- 批准号:
9916706 - 财政年份:2019
- 资助金额:
$ 28.39万 - 项目类别:
University of Michigan Clinical Autoimmunity Center of Excellence
密歇根大学临床自身免疫卓越中心
- 批准号:
10380100 - 财政年份:2019
- 资助金额:
$ 28.39万 - 项目类别:
University of Michigan Clinical Autoimmunity Center of Excellence
密歇根大学临床自身免疫卓越中心
- 批准号:
10165485 - 财政年份:2019
- 资助金额:
$ 28.39万 - 项目类别:
University of Michigan Autoimmunity Center of Excellence, Clinical Research Progr
密歇根大学自身免疫卓越中心临床研究项目
- 批准号:
8842928 - 财政年份:2014
- 资助金额:
$ 28.39万 - 项目类别:
University of Michigan Autoimmunity Center of Excellence, Clinical Research Progr
密歇根大学自身免疫卓越中心临床研究项目
- 批准号:
9480038 - 财政年份:2014
- 资助金额:
$ 28.39万 - 项目类别:
University of Michigan Rheumatic Diseases Core Center
密歇根大学风湿病核心中心
- 批准号:
6781096 - 财政年份:2001
- 资助金额:
$ 28.39万 - 项目类别:
University of Michigan Rheumatic Diseases Research Core Center
密歇根大学风湿病研究核心中心
- 批准号:
7938844 - 财政年份:2001
- 资助金额:
$ 28.39万 - 项目类别:
相似海外基金
Regulation of T lymphocyte apoptosis by GIMAP5
GIMAP5对T淋巴细胞凋亡的调节
- 批准号:
183041 - 财政年份:2009
- 资助金额:
$ 28.39万 - 项目类别:
Studentship Programs
Apoptosis, Signaling Defects and T Lymphocyte Homeostasis in Patients with Cancer
癌症患者的细胞凋亡、信号传导缺陷和 T 淋巴细胞稳态
- 批准号:
7116658 - 财政年份:2006
- 资助金额:
$ 28.39万 - 项目类别:
T Lymphocyte Apoptosis in Hepatitis C Persistence
丙型肝炎持续存在中的 T 淋巴细胞凋亡
- 批准号:
6778153 - 财政年份:2002
- 资助金额:
$ 28.39万 - 项目类别:
T Lymphocyte Apoptosis in Hepatitis C Persistence
丙型肝炎持续存在中的 T 淋巴细胞凋亡
- 批准号:
6929713 - 财政年份:2002
- 资助金额:
$ 28.39万 - 项目类别:
T Lymphocyte Apoptosis in Hepatitis C Persistence
丙型肝炎持续存在中的 T 淋巴细胞凋亡
- 批准号:
6544560 - 财政年份:2002
- 资助金额:
$ 28.39万 - 项目类别:
T Lymphocyte Apoptosis in Hepatitis C Persistence
丙型肝炎持续存在中的 T 淋巴细胞凋亡
- 批准号:
6615695 - 财政年份:2002
- 资助金额:
$ 28.39万 - 项目类别:
T Lymphocyte Apoptosis in Hepatitis C Persistence
丙型肝炎持续存在中的 T 淋巴细胞凋亡
- 批准号:
7095934 - 财政年份:2002
- 资助金额:
$ 28.39万 - 项目类别:
Apoptosis Signaling in T Lymphocyte Leukemia Cells Induced by the TCR/CD3 Complex
TCR/CD3 复合物诱导 T 淋巴细胞白血病细胞的凋亡信号转导
- 批准号:
5222944 - 财政年份:2000
- 资助金额:
$ 28.39万 - 项目类别:
Research Grants
Apoptosis, Signaling Defects and T Lymphocyte Homeostasis in Patients with Cancer
癌症患者的细胞凋亡、信号传导缺陷和 T 淋巴细胞稳态
- 批准号:
7903454 - 财政年份:
- 资助金额:
$ 28.39万 - 项目类别:
Apoptosis, Signaling Defects and T Lymphocyte Homeostasis in Patients with Cancer
癌症患者的细胞凋亡、信号传导缺陷和 T 淋巴细胞稳态
- 批准号:
8121425 - 财政年份:
- 资助金额:
$ 28.39万 - 项目类别: